Treatment of transthyretin (ATTR) amyloidosis in observational study setting clinical trials

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

The MaesTTRo study is looking at people living with a condition called transthyretin amyloidosis (ATTR). It will follow them over time to understand how the condition develops and how current treatments are working in real life. It aims to gather information from around the world.